Related Experiment Videos
Immune regulation by novel costimulatory molecules
Chen Dong1, Roza I Nurieva, Durbaka V R Prasad
1Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195-7650, USA. chendong@u.washington.edu
Immunologic Research
|August 30, 2003
Summary
Novel costimulatory molecules regulate T-cell activation and differentiation. Understanding these pathways, including CD28, CTLA-4, ICOS, PD-1, and B7-H3, is crucial for immune and autoimmune response modulation.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Biology
Background:
- CD4 helper T (Th)-cells and their cytokines are critical regulators of immune and autoimmune responses.
- T-cell activation and differentiation are tightly controlled by costimulatory receptors.
- Key players like CD28 and CTLA-4 establish the threshold for T-cell activation, while ICOS and PD-1 are novel receptors on activated T-cells.
Purpose of the Study:
- To summarize recent advancements in novel costimulatory molecules.
- To elucidate the roles of these molecules in regulating Th cell activation, differentiation, and function.
Main Methods:
- Literature review of recent developments in costimulatory molecule research.
- Analysis of the regulatory roles of novel costimulatory receptors in T-cell responses.
Main Results:
- Identified novel costimulatory receptors such as ICOS and PD-1 on activated T-cells.
- Highlighted the role of B7-H3 in recognizing a putative costimulatory receptor on activated T-cells.
- Detailed the regulatory functions of these molecules in Th cell activation and differentiation.
Conclusions:
- Novel costimulatory molecules significantly influence Th cell activation, differentiation, and function.
- Further research into these pathways offers potential for modulating immune and autoimmune responses.